10 Eyebrow Thinning Patterns Associated With Specific Hormonal Conditions
5. Adrenal Insufficiency and Cortisol-Related Hair Loss

Adrenal insufficiency, including both primary adrenal insufficiency (Addison's disease) and secondary forms caused by pituitary dysfunction, creates a distinctive eyebrow thinning pattern linked to cortisol deficiency and disrupted adrenal hormone production. This condition produces a characteristic diffuse thinning that affects the entire eyebrow region but is often accompanied by changes in hair pigmentation and texture that distinguish it from other hormonal causes. The mechanism involves the complex interplay between cortisol, aldosterone, and adrenal androgens, all of which influence hair follicle function through different pathways. Cortisol deficiency disrupts the normal hair growth cycle by affecting cellular metabolism within follicles, leading to shortened anagen phases and premature entry into telogen. Additionally, the compensatory increase in adrenocorticotropic hormone (ACTH) that occurs in primary adrenal insufficiency can stimulate melanocyte-stimulating hormone (MSH) production, leading to hyperpigmentation of the skin around thinning eyebrows, creating a distinctive clinical presentation. Patients with adrenal insufficiency often report that their eyebrow thinning develops gradually over months to years, accompanied by other symptoms such as fatigue, weight loss, and salt cravings that help distinguish this condition from other causes of eyebrow loss. The thinning pattern may be asymmetric in some cases, particularly when the condition develops secondary to pituitary lesions that affect hormone production unevenly. Laboratory evaluation typically reveals low cortisol levels, elevated ACTH in primary disease, and abnormal responses to stimulation testing. Treatment with appropriate corticosteroid replacement therapy usually leads to stabilization of eyebrow loss and gradual improvement in hair density, though complete restoration may take many months and depends on the extent of follicular damage present at the time of diagnosis.